Table 5. The number of CD 34% cells infused to each patient the viability ranged from 90 to 94%

Publisher： Nova Science Publishers, Inc.

ISSN： 1556-8539

Source： Journal of Stem Cells, Vol., Iss., 2016-01, pp. : 61-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Table 3. Details of the MNC counts, Viability and CD34+ cells per million in each patient at the time of injection

By  

Journal of Stem Cells, Vol. , Iss. , 2016-01 ,pp. : 47-49

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Table 1. Increase in the level of hematopoietic progenitor cells CD34+ in peripheral blood following seven transfusions to a 60-year-old patient of mononuclear fraction of peripheral blood from a 20-year-old donor [6]

By  

Journal of Stem Cells, Vol. , Iss. , 2016-04 ,pp. : 50-49

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Table 2. Volume of bone marrow aspiration from all patients in three sessions of each patient

By  

Journal of Stem Cells, Vol. , Iss. , 2016-01 ,pp. : 47-46

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Characterization of CD34+ Cells

By  

Journal of Stem Cells, Vol. , Iss. , 2017-07 ,pp. : 33-33

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Table 2. Reference values of hematopoietic progenitor cells CD34+ in peripheral blood of healthy individuals of various ages

By  

Journal of Stem Cells, Vol. , Iss. , 2016-04 ,pp. : 50-50

Nova Science Publishers, Inc.

Access to resources Recommend Favorite